Skip to content

GPR146 as a therapeutic target: Linking lipid metabolism with macrophage inflammation in atherosclerosis.

Nov 2026 · Biochemical Pharmacology · pp. 118600 · 0 citations · 48 references
Medicine

Abstract

Atherosclerosis is driven by dyslipidemia and chronic inflammation. GPR146 has emerged as a regulator of cholesterol metabolism; however, whether GPR146 links lipid metabolism with macrophage inflammation during atherosclerosis remains unclear. Apolipoprotein E-deficient (ApoE-/-) mice were fed a high-fat diet for 12 weeks, followed by 4 weeks of intervention with adeno-associated virus (AAV)-mediated hepatic GPR146 knockdown or rosuvastatin treatment. Atherosclerotic lesions and plaque composition were assessed using Oil Red O staining and immunofluorescence. Lipid profiles, oxidized low-density lipoprotein (ox-LDL), and inflammatory markers were evaluated using enzymatic assays, ELISA, and qPCR, respectively. In ox-LDL-stimulated THP-1-derived macrophages, GPR146 was silenced to examine lipid accumulation, inflammatory responses, transcriptomic alterations, and the potential involvement of the JAK-STAT signaling pathway. GPR146 expression increased in atherosclerotic lesions, particularly in macrophage-rich regions. Hepatic GPR146 knockdown reduced atherosclerotic lesion burden, circulating total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels, ox-LDL accumulation, and inflammatory activation within plaques. In macrophages, GPR146 silencing suppressed ox-LDL-induced lipid accumulation, accompanied by reduced CD36 expression and decreased foam cell formation. GPR146 silencing also attenuated pro-inflammatory macrophage activation, as evidenced by reduced expression of inflammatory mediators. Transcriptomic analysis implicated JAK-STAT signaling, with reduced JAK2 and STAT3 expression following GPR146 silencing. Pharmacological inhibition of the JAK-STAT signaling partially recapitulated the anti-inflammatory effects associated with GPR146 knockdown. Together, these findings suggest that GPR146 contributes to lipid metabolic regulation and macrophage inflammatory responses during atherosclerosis and may represent a therapeutic target warranting further investigation.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.